We play a pivotal legal role in the health sector in New Zealand.

​​​Our experienced team has a complete understanding of the changing regulatory environment and legal issues faced by the New Zealand health sector.

Bell Gully is the principal legal services provider to PHARMAC, the Government agency set up to manage public expenditure on pharmaceuticals, and we advise on many aspects of its work. We have particular strengths in health funding and procurement, as well as the medicines system. We have completed significant procurement project work for several District Health Boards (DHBs) and other public sector health procurement agencies who procure on behalf of some or all DHBs.

Work highlights

PHARMAC's principal legal advisor
Advise PHARMAC, the Government agency set up to manage expenditure on pharmaceuticals, as its principal legal advisor. We advise on many aspects of its work including its role in purchasing hospital pharmaceuticals and medical devices on behalf of all district health boards, purchasing strategies, tender processes and contracting, and matters concerning the release of official information that has been referred to the Ombudsman for investigation.

Assisted PHARMAC with the drafting of a provisional agreement with Novartis for the listing and funding of nine new medicines. This has been record-breaking in terms of being the highest number of new medicines funded from one single agreement. It has facilitated reduced costs and is widening access to medicines to an estimated 12,000 patients over five years.